Literature DB >> 19454063

Genital herpes.

Eva Maria Agnes Jungmann1.   

Abstract

INTRODUCTION: Genital herpes is an infection with herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2), and is among the most common sexually transmitted diseases. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent sexual transmission of herpes simplex virus? What are the effects of interventions to prevent transmission of herpes simplex virus from mother to neonate? What are the effects of antiviral treatment in people with a first episode of genital herpes? What are the effects of interventions to reduce the impact of recurrence? What are the effects of treatments in people with genital herpes and HIV? We searched: Medline, Embase, The Cochrane Library and other important databases up to August 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 35 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antivirals, caesarean delivery, condoms, oral acyclovir, psychotherapy, recombinant glycoprotein vaccines, serological screening, and counselling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19454063      PMCID: PMC2943783     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  49 in total

Review 1.  The management of herpes simplex virus infection in pregnancy.

Authors:  J R Smith; F M Cowan; P Munday
Journal:  Br J Obstet Gynaecol       Date:  1998-03

2.  Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

Authors:  G J Mertz; M O Loveless; M J Levin; S J Kraus; S L Fowler; D Goade; S K Tyring
Journal:  Arch Intern Med       Date:  1997-02-10

Review 3.  Treatment of genital herpes.

Authors:  K M Stone; W L Whittington
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

4.  Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group.

Authors:  K H Fife; C S Crumpacker; G J Mertz; E L Hill; G S Boone
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

Review 5.  Psychosocial factors and recurrent genital herpes: a review of prediction and psychiatric treatment studies.

Authors:  D Longo; K Koehn
Journal:  Int J Psychiatry Med       Date:  1993       Impact factor: 1.210

6.  Recurrence rates in genital herpes after symptomatic first-episode infection.

Authors:  J Benedetti; L Corey; R Ashley
Journal:  Ann Intern Med       Date:  1994-12-01       Impact factor: 25.391

7.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

8.  Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.

Authors:  L L Scott; P J Sanchez; G L Jackson; F Zeray; G D Wendel
Journal:  Obstet Gynecol       Date:  1996-01       Impact factor: 7.661

9.  Continuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovir.

Authors:  L H Goldberg; R H Kaufman; T O Kurtz; M A Conant; L J Eron; R L Batenhorst; G S Boone
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

10.  Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations.

Authors:  F M Cowan; A M Johnson; R Ashley; L Corey; A Mindel
Journal:  BMJ       Date:  1994-11-19
View more
  2 in total

1.  An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.

Authors:  Mariaconcetta Sicurella; Francesco Nicoli; Eleonora Gallerani; Ilaria Volpi; Elena Berto; Valentina Finessi; Federica Destro; Roberto Manservigi; Aurelio Cafaro; Barbara Ensoli; Antonella Caputo; Riccardo Gavioli; Peggy C Marconi
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

2.  Does suppressive antiviral therapy for herpes simplex virus prevent transmission in an HIV-positive population? A systematic review.

Authors:  C R Smith; L Pogany; U Auguste; M Steben; Tty Lau
Journal:  Can Commun Dis Rep       Date:  2016-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.